Detalhe da pesquisa
1.
Chromatin conformational changes at human satellite II contribute to the senescence phenotype in the tumor microenvironment.
Proc Natl Acad Sci U S A
; 120(32): e2305046120, 2023 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37523559
2.
Time-series blood cytokine profiles correlate with treatment responses in triple-negative breast cancer patients.
Br J Cancer
; 130(6): 1023-1035, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238427
3.
Long-term outcomes of neoadjuvant trastuzumab emtansine + pertuzumab (T-DM1 + P) and docetaxel + carboplatin + trastuzumab + pertuzumab (TCbHP) for HER2-positive primary breast cancer: results of the randomized phase 2 JBCRG20 study (Neo-peaks).
Breast Cancer Res Treat
; 2024 May 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38767786
4.
Analysis of the interaction between the ORF42 and ORF55 proteins encoded by Kaposi's sarcoma-associated herpesvirus.
Arch Virol
; 169(5): 98, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38619650
5.
Transcriptomic intratumor heterogeneity of breast cancer patient-derived organoids may reflect the unique biological features of the tumor of origin.
Breast Cancer Res
; 25(1): 21, 2023 02 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810117
6.
Oncofertility-related psycho-educational therapy for young adult patients with breast cancer and their partners: Randomized controlled trial.
Cancer
; 129(16): 2568-2580, 2023 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37082910
7.
Chromatin profile-based identification of a novel ER-positive breast cancer subgroup with reduced ER-responsive element accessibility.
Br J Cancer
; 128(7): 1208-1222, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36725920
8.
Real-world data analysis of perioperative chemotherapy patterns, G-CSF use, and FN status in patients with early breast cancer.
Breast Cancer Res Treat
; 201(2): 265-273, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37410318
9.
A risk-based subgroup analysis of the effect of adjuvant S-1 in estrogen receptor-positive, HER2-negative early breast cancer.
Breast Cancer Res Treat
; 202(3): 485-496, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37676450
10.
Childbirth after perioperative systemic therapy in patients with breast cancer: a retrospective single institutional study in Japan.
Jpn J Clin Oncol
; 53(6): 457-462, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974683
11.
Retrospective study on the effectiveness of medroxyprogesterone acetate in the treatment of ER-positive/HER2-negative post-menopausal advanced breast cancer: an additional analysis of the JBCRG-C06 Safari study.
Jpn J Clin Oncol
; 53(3): 203-211, 2023 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36484305
12.
Switch maintenance endocrine therapy plus bevacizumab after bevacizumab plus paclitaxel in advanced or metastatic oestrogen receptor-positive, HER2-negative breast cancer (BOOSTER): a randomised, open-label, phase 2 trial.
Lancet Oncol
; 23(5): 636-649, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35405087
13.
The ELEANOR noncoding RNA expression contributes to cancer dormancy and predicts late recurrence of estrogen receptor-positive breast cancer.
Cancer Sci
; 113(7): 2336-2351, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35415910
14.
Label-free multiphoton excitation imaging as a promising diagnostic tool for breast cancer.
Cancer Sci
; 113(8): 2916-2925, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35579268
15.
Pertuzumab retreatment for HER2-positive advanced breast cancer: A randomized, open-label phase III study (PRECIOUS).
Cancer Sci
; 113(9): 3169-3179, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35754298
16.
Serial circulating tumor DNA monitoring of CDK4/6 inhibitors response in metastatic breast cancer.
Cancer Sci
; 113(5): 1808-1820, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-35201661
17.
Clinical significance of the neutrophil-to-lymphocyte ratio in oligometastatic breast cancer.
Breast Cancer Res Treat
; 196(2): 341-348, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36153381
18.
Immune microenvironment, homologous recombination deficiency, and therapeutic response to neoadjuvant chemotherapy in triple-negative breast cancer: Japan Breast Cancer Research Group (JBCRG)22 TR.
BMC Med
; 20(1): 136, 2022 04 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-35462552
19.
Trastuzumab and fulvestrant combination therapy for women with advanced breast cancer positive for hormone receptor and human epidermal growth factor receptor 2: a retrospective single-center study.
BMC Cancer
; 22(1): 36, 2022 Jan 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34983437
20.
Factors associated with overall survival after recurrence in patients with ER-positive/HER2-negative postmenopausal breast cancer: an ad hoc analysis of the JBCRG-C06 Safari study.
Jpn J Clin Oncol
; 52(6): 545-553, 2022 May 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35296894